Centro Nacional de Investigaciones Cardiovasculares Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis

    EMBO molecular medicine, Vol. 14, Núm. 3, pp. e14552